TrialBritish journal of cancer2006

A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.

M E Burge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.